Compound Detail
CHEMBL4638277
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O
Basic Information
| ChEMBL ID | CHEMBL4638277 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GHOMNMJVWVKAOZ-PZJWPPBQSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
552.5
MW (Da)
4.12
ALogP
7
HBA
2
HBD
106.2
PSA (Ų)
0.39
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 8.72 | 7.81 | 1.9 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK | IC50 | = | 1.9 | nM | 8.72 | Inhibition of BTK in human whole blood assessed as reduction in autophosphorylat... | 32832028 |
| Tyrosine-protein kinase BTK | IC50 | = | 125.0 | nM | 6.9 | Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimula... | 32832028 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32832028 | 10.1021/acsmedchemlett.0c00249 | Tyrosine-protein kinase BTK | 2 |
| 32832028 | 10.1021/acsmedchemlett.0c00249 | No relevant target | 1 |
| 32832028 | 10.1021/acsmedchemlett.0c00249 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine